Treatments:Diabetes
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<td style="width:25%; vertical-align:top;border-width:1px;"> | <td style="width:25%; vertical-align:top;border-width:1px;"> | ||
=====Dipeptidyl Peptidase-4 Inhibitor===== | =====Dipeptidyl Peptidase-4 Inhibitor===== | ||
| - | * [[Galvus]] - Generic: Vildagliptin | + | * [[Galvus]] - Generic: [[Vildagliptin]] |
* [[Januvia]] - Generic: Sitagliptin [[Januvia (sitagliptin)]] | * [[Januvia]] - Generic: Sitagliptin [[Januvia (sitagliptin)]] | ||
| - | * [[Onglyza]] - Generic: Saxagliptin | + | * [[Onglyza]] - Generic: [[Saxagliptin]] |
=====[[Peroxisome Proliferator-Activated Receptor]] Agonist===== | =====[[Peroxisome Proliferator-Activated Receptor]] Agonist===== | ||
| - | * [[Actos]] - Generic: Pioglitazone | + | * [[Actos]] - Generic: [[Pioglitazone]] |
| - | * [[Avandia]] - Generic: Rosiglitazone | + | * [[Avandia]] - Generic: [[Rosiglitazone]] |
</td> | </td> | ||
</tr> | </tr> | ||
</table> | </table> | ||
Revision as of 08:03, 24 January 2019
Dipeptidyl Peptidase-4 Inhibitor
Peroxisome Proliferator-Activated Receptor Agonist
|
Proteopedia Page Contributors and Editors (what is this?)
Alexander Berchansky, David Canner, Michal Harel, Karsten Theis
